Beyond the OCM: How Are Commercial Payers & Employers Delivering Value-Based Cancer Care? Part 1


Experts from The US Oncology Network discuss the future of value-based cancer care, and what practices can do as the Oncology Care Model expires.

In this webinar from The American Journal of Managed Care®'s Oncology Value Coalition, experts from The US Oncology Network discussed the future of value-based cancer care.

Despite many successes, the Oncology Care Model (OCM) is set to expire in July 2022, with no replacement on the horizon. That doesn't mean the lessons of the OCM will be forgotten, but continuing the quality care efforts will be difficult. How will practices continue team-based care, patient navigation, and other enhanced services?

The speakers were:

  • Rhonda Henschel, senior director of payer solutions, The US Oncology Network
  • Ben Jones, vice president of government relations and public policy
    McKesson Specialty Provider Organization, The US Oncology Network
  • Stuart Staggs, senior director of strategic programs, The US Oncology Network
  • Lalan Wilfong, MD,vice president of payer relations and practice transformation, The US Oncology Network

In segment 1, they discussed lessons learned from the OCM.

Watch Segment 2.

Watch Segment 3.

Watch Segment 4.

Related Videos
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Screenshot of Christine Pfaff, RPh, during a Zoom video interview
dr meredith mckean
Jennifer Sturgill, DO, Central Ohio Primary Care
Kristin Oaks, DO, Central Ohio Primary Care
dr erin gillaspie
Nick Ferreyros, Community Oncology Alliance
Kristine Slam, MD, FACP, Central Ohio Surgical Associates
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Related Content
© 2023 MJH Life Sciences
All rights reserved.